Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on STI571. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation method for high-purity Imatinib exceeding 99.5% purity. Optimized solvent recycling and mild conditions ensure cost reduction in pharmaceutical manufacturing.
Patent CN102603710A reveals a novel route for Imatinib intermediates. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.